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All health care professionals are responsible to ensure that all patients in their field receive 
care according to the highest standards. As a health care professional, it is not sufficient to 
ask, “what is the right thing to do?” We must also ask, “are we doing the right thing in the 
right way?” To ensure that all patients receive the highest quality of care, patient treatment 
needs to be continuously reviewed and improved.   
This master thesis was written as part of the subject MED-3950 at the University of Tromsø 
The Arctic University of Norway and is my contribution to improving the quality of care for 
patients receiving fast-track primary total knee arthroplasty at UNN Tromsø. 
The results from this master thesis were presented at the annual meeting of the Norwegian 
Society of Anaesthesiology in October 2017. The travel- and hotel costs related to this 
meeting were covered by The Surgical- and Critical Care Clinic at UNN Tromsø. The master 
thesis received no additional financial funding.  
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Introduction: A new local infiltration analgesia (LIA) protocol was implemented for fast-track 
primary total knee arthroplasty (TKA) at UNN Tromsø in January 2017. The objective of this 
master thesis was to evaluate the new protocol, as well as postoperative pain, postoperative 
nausea and vomiting (PONV) and patient satisfaction following fast-track primary TKA at 
UNN Tromsø.  
Materials and methods: A prospective study was performed at UNN Tromsø running from 
12 January 2017 until 20 June 2017. All patients who received fast-track primary TKA at UNN 
Tromsø during the study period were included. Data concerning adherence to the new 
protocol was collected from the electronical health record. Postoperative pain, PONV and 
patient satisfaction were assessed at seven points during the first 24 hours postoperative 
using a specific pain- and satisfaction form.  
Results: 28 patients were recruited to the study and included for analysis. Only three 
patients received premedication according to the new protocol and only nine patients 
received postoperative medication according to the new protocol. Most patients received 
too low dose of LIA according to the new protocol and timing of antibiotic prophylaxis was 
wrong in many of the patients. Median postoperative resting pain level (NRS) ranged 0-4 
during the first 24 hours postoperative. A total of seven patients reported severe pain (NRS ≥ 
7) at one or more of the assessments. The highest incidence of PONV was recorded in six 
patients at two separate assessments. Patient satisfaction was generally high, but four 
patients were unsatisfied with their patient journey.  
Conclusion: Adherence to the new LIA protocol for fast-track primary TKA at UNN Tromsø 
was low. Despite low adherence to the new protocol patient satisfaction following fast-track 
primary TKA at UNN Tromsø was high. Postoperative pain scores and PONV following fast-
track primary TKA at UNN Tromsø were acceptable but may be improved with increased 






Glossary and abbreviations  
ASA-classification American Society of Anesthesiologists Classification.  
Bds Bis die sumendum, “two times a day”.  
BMI Body mass index (kg/m2).  
EHR Electronical health record.  
Fast-track surgery A multimodal approach to patient care using evidence-based 
perioperative interventions aiming to enhance postoperative 
recovery, decrease morbidity and convalescence as well as 
reduce length of hospital stay. 
FNB Femoral nerve block. 
Intraoperative Relating to the time during a surgical procedure. 
LIA Local infiltration analgesia. Pain management technique 
involving intraoperative administration of a local anaesthetic 
in various combinations with epinephrine, nonsteroidal anti-
inflammatory drugs, opioids and steroids to the surgical 
wound.  
NPR-number(s). Norwegian patient registry number(s).  
NRS Numeric rating scale. Used to measure pain and ranges from 
“0” (no pain) to “10” (worst pain imaginable).  
NSAIDS Nonsteroidal anti-inflammatory drugs.  
Opioid naive Patient not using any opioids upon hospitalization.  
PACU Post-Anaesthesia Care Unit.  
Perioperative  Relating to the time before, during, and after a surgical 
procedure.  
PJI Prosthetic joint infection.  
PONV Postoperative nausea and vomiting.  
Postoperative Relating to the time after a surgical procedure.  






Primary TKA Primary total knee arthroplasty. The first total knee 
arthroplasty performed on a specific knee joint.  
Prn Pro re nata, “as needed”.  
PROSPECT working group Procedure specific postoperative pain management working 
group.  
Revision TKA Revision total knee arthroplasty. An additional total knee 
arthroplasty performed on a specific knee joint after a primer 
total knee arthroplasty have been performed.  
TKA Total knee arthroplasty.  







1.1 Total knee arthroplasty  
The normal knee joint functions as a complex hinge, primarily allowing flexion and extension 
but also some rotation and gliding. The knee joint consists of three compartments: medial, 
lateral and patellofemoral. The articular surfaces of each compartment are covered with 
cartilage that provides a smooth, lubricated surface for articulation and facilitates 
transmission of loads to the underlying subchondral bone. However, osteoarthritis, 
inflammatory arthritis, avascular necrosis, tumours, or congenital deformities may cause 
damage to the cartilage and a subsequent deterioration of its function (1). This may lead to 
one or more of the compartments needing replacement. Replacing one or more of the 
compartments can be performed with an orthopaedic procedure called knee arthroplasty. 
Knee arthroplasties can be either partial (unicompartmental) or total (bi- or 
tricompartmental).  
Total knee arthroplasty (TKA) is a major orthopaedic procedure that involves a resection of 
the diseased cartilage and articular surfaces of the medial- and lateral compartment 
followed by a resurfacing with fitted metal- or polyethylene prosthetic components. In 
addition, a resection and resurfacing of the patellofemoral compartment may also be 
performed. The first TKA performed on a specific knee joint is called primary TKA. Additional 
TKAs performed on the same knee joint are called revision TKAs. If successful, primary TKA 
can lead to pain relief, to restoration of mobility and to improved quality of life (2). 
The incidence of primary TKA in Norway has increased progressively over the last few years 
(3). In 2016 about 5500 primary TKAs were performed in Norway, making it a common 
orthopaedic procedure (3). The main reason for performing primary TKA is idiopathic 
osteoarthritis. In 2016 more than 90% of the primary TKAs performed in Norway reported 
idiopathic osteoarthritis as underlying cause for the procedure (3). Primary TKA is most often 
received by elderly patients. In 2016 more than 80% of patients who received primary TKA in 






1.2 Anaesthesia and analgesia for primary TKA 
Despite the beneficial long-term effects of primary TKA (2), the procedure is associated with 
severe early postoperative pain and effective analgesia is therefore paramount (4). However, 
most patients who receive primary TKA are elderly. As a result, many of the patients 
receiving primary TKA will also have comorbid diseases. Thus, providing adequate 
anaesthesia and analgesia while keeping side effects to a minimum is challenging. Optimal 
perioperative analgesia will enhance functional recovery, including timely recovery of knee 
mobility, and reduce postoperative morbidity (4, 5).  
In 2008 the Procedure Specific Postoperative Pain Management (PROSPECT) working group 
published evidence-based consensus recommendations for effective management of 
postoperative pain following primary TKA (4). General anaesthesia or spinal anaesthesia with 
local anaesthetic combined with femoral nerve block (FNB) was recommended as primary 
technique for surgery and postoperative pain. Paracetamol and conventional non-steroidal 
anti-inflammatory drugs (NSAIDS) or COX-2-selective inhibitors, plus intravenous (iv) strong 
opioids (high-intensity pain) or weak opioids (moderate- to low-intensity pain), together with 
cooling and compression techniques, were recommended as supplement to general- or 
spinal anaesthesia in combination with FNB. 
Since 2008 research on postoperative pain management following primary TKA has 
progressed. Over the last few years local infiltration analgesia (LIA) has been increasingly 
used. LIA is a simple surgeon-administered technique that involves intraoperative 
administration of a local anaesthetic in various combinations with epinephrine, NSAIDS, 
opioids and steroids to the surgical wound. LIA is effective for managing acute postoperative 
pain following primary TKA (6, 7), and provides similar analgesia compered to FNB (8). 
However, LIA might be preferable over FNB following primary TKA due to the simple 
administration technique and the increased risk of falling associated with FNB (9). In addition 
to LIA, recent research has shown that administration of intraoperative high-dose iv 
corticosteroids reduces postoperative pain and postoperative nausea and vomiting (PONV) 






1.3 New LIA protocol for fast-track primary TKA at UNN Tromsø  
A new anaesthesia protocol containing LIA (hereinafter referred to as “new protocol”) for 
fast-track primary TKA was implemented at UNN Tromsø 31 January 2017 (appendix A). Fast-
track surgery uses a multimodal approach to patient care using evidence-based 
perioperative interventions aiming to enhance postoperative recovery, decrease morbidity 
and convalescence as well as reduce length of hospital stay. This multimodal concept of fast-
track surgery has shown substantial success for primary TKA and lead to reduced morbidity 
and length of hospital stay (11).  
The new protocol included spinal anaesthesia with local anaesthetic as primary technique to 
provide adequate anaesthesia. To provide adequate analgesia the new protocol included 
multimodal pain management with paracetamol, NSAIDs and opioids given both 
preoperative and postoperative, as well as LIA and high-dose iv corticosteroids 
intraoperatively. Additionally, the new protocol also included several measures not aimed at 
analgesia and anaesthesia e.g. thromboembolic prophylaxis, antibiotic prophylaxis, bleeding 
prophylaxis, choice of equipment, patient monitoring etc.   
Nurses and physicians at the Anaesthesia Department, Postoperative Care Unit (PACU) and 
Orthopaedic ward were responsible for ensuring that patient treatment was given according 
to the new protocol.  
1.4 Objective of the master thesis 
The objective of this master thesis was to evaluate the new protocol for fast-track primary 
TKA at UNN Tromsø. The following research questions were defined: 
- Assess adherence to the new protocol for fast-track primary TKA at UNN Tromsø. 
- Assess postoperative pain, PONV and patient satisfaction following fast-track primary 







2 Materials and methods  
2.1 Study design 
A prospective study was performed at UNN Tromsø running from 12 January 2017 until 20 
June 2017. The study was commenced 19 days before the new protocol was officially 
implemented. However, clinical practise for fast-track primary TKA at UNN Tromsø was 
already adapted to the new protocol by study start. Thus, all patients who received fast-
track primary TKA at UNN Tromsø during the study period were treated in accordance to the 
new protocol.  
2.2 Study population 
All patients who received fast-track primary TKA at UNN Tromsø during the study period 
were included in the study and analysis.  
2.3 Data collection 
2.3.1 Paint- and satisfactory form 
A specific pain- and satisfaction form (hereinafter referred to as “form”) was made for data 
collection (appendix B). Data from all patients included in the study were collected using this 
form. Assessments were performed seven times during the first 24 hours postoperative by 
nurses at the PACU and Orthopaedic ward or by author Arnstein Berg at the following time 
points: 
1. Arrival PACU (0 hours postoperative) 
2. 1 hour postoperative 
3. 2 hours postoperative 
4. Discharge PACU 
5. Arrival Orthopaedic Ward 
6. Evening operation day (8 hours postoperative) 
7. Postoperative day 1 (24 hours postoperative) 
The form consisted of five questions concerning postoperative pain, two questions 






numeric rating scale (NRS) ranging from “0” (no pain) to “10” (worst pain imaginable) was 
used. The questions on the form are shown below (please note that the questions have been 
translated from Norwegian to English):  
Postoperative pain 
➢ Pain at rest (NRS 0-10)?  
➢ If current resting pain, where is the worst pain focus located (anteriorly, medially, 
laterally, posteriorly or globally)? 
➢ Maximal resting pain since last assessment (NRS 0-10)? 
➢ Minimal resting pain since last assessment (NRS 0-10)? 
➢ Average resting pain since last assessment (NRS 0-10)? 
PONV 
➢ Nausea now or since last assessment (yes/no)? 
➢ Vomiting now or since last assessment (yes/no)? 
Patient satisfaction 
➢ Current satisfaction (Very unsatisfied, unsatisfied, satisfied, more than satisfied, very 
satisfied)? 
Early in the study period the three questions concerning maximal-, minimal- and average 
resting pain since last assessment were removed from further data collection and excluded 
from analysis. This was done because the patients included in the study could not accurately 
recall the level of pain experienced in the periods between each assessment.  
When assessed for postoperative pain, some patients were assigned NRS scores with 
decimal numbers e.g. NRS 4,5. Some patients were also assigned NRS scores using two 
numbers e.g. 4-5 or 4/5. In the analysis, all NRS scores with decimal numbers or two 
numbers were rounded up to the nearest whole number.  
Some of the patients included in the study who were asked to locate the worst pain focus 






patients described the worst pain focus to be located anteromedially instead of anteriorly or 
medially. Therefore, new anatomical categories were constructed during analysis based on 
clinical relevance. Patients who located the worst pain focus anteriorly, medially or 
anteromedially were categorised having an “anteromedial worst pain focus”. Patients who 
located the worst pain focus posteriorly were categorised having a “posterior worst pain 
focus”. Patients who did not locate the worst pain focus anteriorly, medially, anteromedially 
or posteriorly were categorised having “other worst pain focuses”.  
When assessed for current satisfaction, most patients had difficulty distinguishing between 
the categories indicating various levels of satisfaction and unsatisfaction. This created 
uncertainty regarding the difference between the categories used to measure patient 
satisfaction. Because of this uncertainty the various levels of satisfaction were combined into 
one category called “satisfied” and the two categories indicating various levels of 
unsatisfaction were combined into one category called “unsatisfied”. 
The two questions concerning PONV on the form were combined during analysis to 
“Nausea/vomiting now or since last assessment”. This was done because there were few 
incidents of vomiting during the study period. The combined PONV question used in analysis 
was answered with “yes” if one or both of the original PONV questions on the form were 
answered with “yes”. 
2.3.2 Electronic health record 
Demographics and data concerning adherence to the new protocol were collected from the 
electronical health record (EHR) DIPS Arena. The EHR-data was collected by the author 
Arnstein Berg with the help from mentor Lars Marius Ytrebø. Adherence to the new protocol 
was scrutinized and discussed with professor Ytrebø. However, the final decision regarding 
protocol adherence was made by professor Ytrebø. 








➢ Body mass index (BMI) 
➢ Classification according to the American Society of Anesthesiologists (ASA-
classification) 
➢ Preoperative opioid use (opioid-naive defined as not using any opioids upon 
hospitalization) 
➢ Knee (left/right) 
Preoperative measures according to the new protocol assessed for adherence: 
➢ Thromboembolic prophylaxis with dalteparin 
➢ Premedication: 
▪ Oral Paracetamol 1000 mg for patients <70 kg or 2000 mg for patients >70 kg 
▪ Oral sustained-release naproksen 500 mg/ esomeprazol 20 mg 
▪ Oral sustained-release tapentadol 50 mg. Alternatively for patients >70 years 
oral sustained-release oksykodonhydroklorid 10 mg 
▪ No preoperative benzodiazepines 
➢ Preoperative bladder emptying controlled and documented in the anaesthesia 
record by Orthopaedic ward nurse 
Intraoperative measures according to the new protocol assessed for adherence: 
➢ Spinal anaesthesia with bupivacaine 0,5% plain. 
➢ Antibiotic prophylaxis with cefalotin 2 g iv qds according to national guidelines (12). 
First dose 30-60 minutes before the procedure, second dose 90 minutes after the 
first dose, then 2 g every 90 minutes up to four doses in total.  
➢ Tranexamic acid 10 mg/kg intravenously if no contraindications. First dose 15 
minutes before tourniquet is released. Second dose 3 hours after first dose. 
➢ Dexametasone 16 mg iv.   
➢ LIA with ropivacaine 2 mg/ml with adrenalin 5 μg/ml (total volume 120-150 ml). 
Postoperative measures according to the new protocol assessed for adherence: 






▪ Oral Paracetamol 1000 mg qds or 1500 mg qds. 
▪ Oral sustained-release naproksen 500 mg/ esomeprazol 20 mg bds. 
▪ Oral sustained-release tapentadol 50 mg bds. 
▪ Iv Morphine or oral oksykodonhydroklorid 5 mg prn. 
2.5 Data management and statistic 
Data collected from the EHR was stored using Norwegian Patient Registry numbers (NPR-
numbers). All non-electronical data, including the forms, were securely kept in a locked 
office at UNN Tromsø.  
IBM SPSS Statistics 24 was used to produce descriptive statistics of the data collected. 
Missing patient data were excluded pairwise during analysis.  
2.6 Ethics  
Necessary approval from the data protection officer at UNN Tromsø was secured in advance 
of the study (appendix C). The study qualified as an internal quality assurance study. Thus, 
no additional approval from the regional committee for medical and health research ethics 









3 Results  
28 patients were recruited to the study and all patients were included in the analyses. 
Demographic data are shown in Table 1.  
3.1 Adherence to the new protocol  
Data on adherence to preoperative measures are presented in Table 2. Premedication was 
received by three patients according to the new protocol. Most patients received too low 
dose of preoperative paracetamol and half of the patients did not receive preoperative 
naproksen/ esomeprazol. Preoperative tapentadol or oksykodonhydroklorid was received by 
most patients. Preoperative bladder emptying was usually controlled, but often not 
documented correctly. All patients received thromboembolic prophylaxis according to the 
new protocol.  
Data on adherence to intraoperative measures are presented in Table 3. Spinal anaesthesia 
was received by 26 patients. The remaining two patients received general anaesthesia. LIA 
was received by 26 patients, but most patients received a lower dose than stated by the new 
protocol. Half of the patients did not receive dexametasone according to the new protocol. 
All patients received tranexamic acid, but two patients received the second dose at the 
wrong time.  
Data on adherence to antibiotic prophylaxis are presented in Table 4. All patients received 
the first and second dose of prophylactic antibiotics and nearly all patients received the third 
and fourth dose with prophylactic antibiotics. However, most patients received the doses of 
prophylactic antibiotics at the wrong time according to national guidelines.  
Data on adherence to postoperative measures are presented seen in Table 5. Only nine 
patients received correct postoperative medication. Nearly all patients received 
postoperative paracetamol, but half of the patients did not receive postoperative 






3.2 Postoperative pain, PONV and patient satisfaction  
Figure 1 shows a box-plot displaying the postoperative pain scores. Median resting pain level 
(NRS) at arrival in the PACU, 1 hour postoperative and 2 hours postoperative was 0. Median 
resting pain level at discharge from the PACU and arrival at the Orthopaedic ward was 2. 
Median resting pain level at evening operation day and postoperative day 1 was  4. A total of 
seven patients reported severe pain (NRS ≥ 7) at one or more assessments.  
The locations of the worst pain focus are presented in Table 6. Maximum pain was usually 
located anteromedially. Few patients reported severe pain at the back of the knee joint. 
Few patients reported PONV (Table 7). The highest incidence of PONV was reported by six 
patients at the evening operation day and postoperative day 1. 
Satisfaction score is presented in Table 8. Patient satisfaction was in general high. However, 








The results from this study showed that adherence to the new protocol for fast-track 
primary TKA at UNN Tromsø was disappointingly low. However, patient satisfaction was 
high. The incidence of postoperative pain and PONV following fast-track primary TKA at UNN 
Tromsø were relatively low, yet there are still room for significant improvements. 
4.1 Adherence to the new protocol 
Only three patients received premedication according to the new protocol. This was mainly 
due to patients receiving too low dose of preoperative paracetamol and not receiving 
preoperative naproksen/ esomeprazol. The new protocol stated that patients < 70 kg should 
receive 1000 mg oral paracetamol preoperatively and that patients > 70 kg should receive 
2000 mg oral paracetamol preoperatively. No documentation was found as to why most 
patients received too low dose of preoperative paracetamol. One possible explanation might 
be that the physicians prescribing premedication were unaware that patients > 70 kg should 
receive 2000 mg oral paracetamol preoperatively instead of the standard dose of 1000 mg. 
This may have led to most patients receiving the standard dose of 1000 mg paracetamol 
regardless of weight. An initial dose of 2000 mg oral paracetamol is likely to achieve earlier 
meaningful plasma concentrations than 1000 mg, is considered safe and may lead to 
improved postoperative pain (13, 14). Thus, the fact that most patients in this study received 
too low dose of preoperative paracetamol may have led to increased postoperative pain.  
In addition to most patients receiving to low dose of preoperative paracetamol, half of the 
patients did not receive preoperative naproksen/ esomeprazol. One patient did not receive 
preoperative naproksen/ esomeprazol due to allergy. However, no documentation was 
found as to why the remaining 12 patients did not receive preoperative naproksen/ 
esomeprazol. This may have been due to contraindications such as allergy or severe liver-, 
heart- or kidney impairment. However, it may also have been due to unawareness of the 
new protocol. The fact that half of the patients did not receive preoperative naproksen/ 






In contrary to preoperative paracetamol and naproksen/ esomeprazol, most patients 
received preoperative tapentadol or oksykodonhydroklorid. However, six patients did not 
receive preoperative tapentadol or oksykodonhydroklorid. As with preoperative 
paracetamol and naproksen/ esomeprazol, no documentation was found as to why. Again, 
this may have been due to contraindications or unawareness of the new protocol.  
Despite the new protocol, three patients received preoperative Benzodiazepines. One 
patient received preoperative Benzodiazepines as part of regular medication. No 
documentation was found as to why the other two patients received preoperative 
benzodiazepines. A possible explanation may be anxiety prior to the procedure.  
Preoperative bladder emptying was usually controlled but often not documented correctly. 
The new protocol stated that preoperative bladder emptying should be controlled by the 
Orthopaedic ward nurse and documented in the anaesthesia record. Usually preoperative 
bladder emptying was documented by the Orthopaedic ward nurses in the EHR but not in 
the anaesthesia record. More importantly, preoperative bladder emptying was not 
documented in six patients. Failure of preoperative bladder emptying increases the risk of 
postoperative urinary retention, which may lead to increased postoperative morbidity (15, 
16).   
All patients received thromboembolic prophylaxis according to the new protocol. The 
incidence of venous thromboembolic disease following elective knee surgery may be as high 
as 60% without prophylaxis (17). Deep venous thrombosis and pulmonary embolism are 
both serious adverse effects that may cause readmissions, prolongation of hospital stay and 
death. Adequate thromboembolic prophylaxis following fast-track primary TKA is therefore 
paramount.  
All patients received spinal anaesthesia according to the new protocol, except for two 
patients who received general anaesthesia. General anaesthesia is used in fast-track primary 
TKA when patients refuse spinal anaesthesia or wish to sleep during the procedure. When 
used for TKA, general anaesthesia is equally effective to and without increased morbidity 






Nearly all patients in this study received LIA, but 22 patients received a lower dose than 
stated by the new protocol. During the study period it was discovered that a second protocol 
for fast-track primary TKA, used by the surgical nurses, stated a lower LIA dose than the new 
protocol. If the LIA dose administered by the orthopaedic surgeon(s) was based on the 
protocol used by the surgical nurses this may explain why most patients received a lower 
dose of LIA than stated by the new protocol. However, it is unclear if the difference in LIA 
doses affected the postoperative pain. Irrespectively of this, different protocols concerning 
the same patients and same procedures should state the same treatment to avoid potential 
confusion and mistreatment.  
Half of the patients in this study did not receive intraoperative dexametasone according to 
the new protocol. No documentation was found as to why only half of the patients received 
dexametasone. As stated in the introduction, administration of intraoperative high-dose 
corticosteroids has shown to reduce postoperative pain and PONV following primary TKA. 
The fact that half of the patients in this study did not receive dexametasone may have led to 
increased postoperative pain and PONV. 
Close to all patients in this study received tranexamic acid according to the new protocol. 
Perioperative blood loss and the need for transfusions following primary TKA may lead to 
increased length of hospital stay (19). Tranexamic acid is a safe, cost-effective method of 
reducing perioperative blood loss and the need for transfusions (20). As stated in the 
introduction fast-track surgery aims to reduce length of hospital stay. Therefore, adequate 
bleeding prophylaxis with tranexamic acid, is important in fast-track primary TKA.  
Antibiotic prophylaxis for total joint arthroplasty has shown to be effective (21). In a large 
Norwegian register study, four doses of iv prophylactic antibiotics on the day of surgery 
were more effective than fewer doses in primary total hip arthroplasty (22). This may also be 
true for primary TKA. However, other studies have found a single dose of prophylactic 
antibiotics to be equally effective compared to multiple doses in hip- and knee arthroplasties 
(23). Nevertheless, the timing of preoperative prophylactic antibiotics is crucial to ensure 






in knee arthroplasties prophylactic antibiotics should be finished at least 10 minutes before 
application of a tourniquet (25). For primary TKA national guidelines strongly recommend 
antibiotic prophylaxis with cefalotin 2 g iv qds (12). First dose should be given 30-60 minutes 
before the procedure, second dose 90 minutes after the first dose, then 2 g every 90 
minutes up to four doses in total. All patients in this study received four doses of 
prophylactic antibiotics, except for two patients that did not receive the fourth dose. 
However, many of the patients received the prophylactic antibiotics at the wrong time 
according to national guidelines. Especially the last two doses. Failure to provide adequate 
antibiotic prophylaxis may lead to increased risk of periprosthetic joint infection (PJI). PJI 
occurs in 1-2% of knee arthroplasties and is the most common cause for revision TKA (26). 
PJI is a tremendous burden to both patients and health-care institutions (26), and preventing 
PJI should therefore be of the utmost importance in all arthroplasties, including fast-track 
primary TKAs.  
Postoperative medication was received by nine patients according to the new protocol. A 
slight improvement when compared to the preoperative medication. In contrary to 
preoperative paracetamol, close to all patients received postoperative paracetamol 
according to the new protocol. Yet, only half of the patients received postoperative 
naproksen/ esomeprazol. Fewer patients received postoperative tapentadol compared to 
preoperative tapentadol/oksykodonhydroklorid (18 vs 22 patients). No documentation was 
found as to why 13 and 10 patients respectively did not receive postoperative naproksen/ 
esomeprazol and tapentadol, except for one patients that did not receive naproksen/ 
esomeprazol due to allergy. Like for patients that did not receive preoperative naproksen/ 
esomeprazol and tapentadol/oksykodonhydroklorid, this may have been due to 
contraindications or unawareness of the new protocol. All patients without contraindications 
should receive both pre- and postoperative naproksen/ esomeprazol and 
tapentadol/oksykodonhydroklorid to improve postoperative pain.   
An important secondary finding of this study was the lack of documentation regarding 






dosage and timing of the medication. In some cases, it was also difficult to assess which drug 
that was prescribed. In addition, documentation as to why most patients did not receive 
medication according to the new protocol was missing. The low level of documentation 
regarding patient medication is an alarming finding. Lack of documentation has a great 
potential for harm and should be corrected in the follow-up of this investigation. 
4.2 Postoperative pain, PONV and patient satisfaction 
The PACU at UNN Tromsø aims to achieve resting pain level (NRS) ≤ 3 for all patients. The 
median resting pain level in this study was ≤ 3 at arrival PACU, 1 hour postoperative, 2 hours 
postoperative and discharge PACU, as well as at arrival Orthopaedic ward. However, at 
evening operation day and postoperative day 1 the median resting pain level had increased 
to 4. Patients are mobilised following arrival at the Orthopaedic ward which may contribute 
to increased resting pain. In addition, the intensity of patient surveillance is lower at the 
Orthopaedic ward compared to the PACU, and this may lead to delayed acknowledge of pain 
and a delay in treatment with adequate analgesia. Thus, the increase in median resting pain 
level following arrival at the Orthopaedic ward is not unexpected.  
Examination of the data showed that a total of seven patients reported severe pain at one or 
more assessments. It is unclear why these patients suffered from severe pain and why 
adequate analgesia was not provided. However, none of the seven patients received 
premedication according to the new protocol and only two of the patients received 
postoperative medication according to the new protocol. Additionally, only one of the seven 
patients received LIA according to the new protocol and only one patient received 
dexametasone according to the new protocol. All three patients that received preoperative 
benzodiazepines were among the seven patients that reported severe postoperative pain. It 
is unclear why these patients received preoperative benzodiazepines, but one possible 
explanation, as stated in the results, may be anxiety prior to the procedure. Patients with 
preoperative anxiety are known to have increased risk for postoperative pain (27, 28). This 
may help explain why the three patients that received preoperative benzodiazepines also 






reported severe postoperative pain was also not opioid naïve prior to the procedure. 
Patients that are opioid tolerant requires significantly higher doses of opioids to treat 
postoperative pain following TKA (29), and may also experience greater postoperative pain 
than opioid naïve patients (29).  
Previous studies have found mean resting pain levels at 24 hours postoperative ranging from 
0,89-5,53 in patients receiving primary TKA with intraoperative administration of LIA (7). 
Thus, the median resting pain level at 24 hours postoperative in this study does not differ 
from that found in previous studies. Nevertheless, it is likely to believe that postoperative 
pain following fast-track primary TKA at UNN Tromsø may be improved with increased 
adherence to the new protocol.  
The worst pain focus was usually located anteromedially by the patients in this study. A 
proximal FNB can effectively treat anteromedial knee pain (30, 31), but may also cause 
paralysis of the quadriceps muscles, delay ambulation and increase risk of falling following 
primary TKA (9). The ideal nerve block following primary TKA should provide effective 
analgesia and be motor sparing. However, the optimal nerve block for primary TKA is not 
settled and further research is required (30). Nevertheless, FNB should be considered for 
anteromedial knee pain following primary TKA when other pain management modalities 
have failed.  
Overall few patients reported PONV. The highest incidence of PONV was reported by six 
patients at evening operation day and at postoperative day 1. Examination the data showed 
that a total of 12 patients reported PONV during the study period, but only two patients 
reported PONV at more than one assessment. This indicates that PONV was treated 
effectively when occurring in most patients. Three out of the twelve patients that reported 
PONV vomited. Two out of the three patients that vomited (patient 8 and 15) received 
general anaesthesia. However, patient 8 and 15 also suffered from severe pain at one or 
more of the assessments. The incidence of PONV is higher after receiving general 
anaesthesia compared to regional anaesthesia (32), but may also be higher with increased 






suffered from severe pain also reported PONV. In addition to the pain itself, patients with 
severe pain may also receive high doses of postoperative opioids, which has shown to 
increase PONV in a dose-response relationship (34). Irrespective of cause, PONV is an 
important clinical outcome to avoid and is often rated worse than postoperative pain by 
patients (35).  
Patient satisfaction following fast-track primary TKA at UNN Tromsø was high. A total of four 
patients were unsatisfied: two at arrival in the PACU, one at evening operation day and one 
at postoperative day 1. Examination of the data showed that three out of the four  patients 
reported severe pain at the same assessment as they were unsatisfied. The fourth patient 
had also experienced severe pain, but prior to the assessment. Additionally, PONV was 
reported by one of the four patients on the same assessment. During the study period it was 
not registered why the four patients were unsatisfied. However, it is likely to believe that 
severe postoperative pain and PONV contributed.  
4.3 Strengths and Limitations 
This study has several strengths, primarily that it was conducted prospectively. During the 
five-month study period all patients who received fast-track primary TKA at UNN Tromsø 
were recruited to the study and included in the analysis. Postoperative pain, PONV and 
patient satisfaction were assessed objectively in all patients using a specific pain- and 
satisfactory form. Data was collected from the EHR by two persons in close collaboration 
(the author and anaesthesiologist Ytrebø) and analysis of all data was done by the same 
person (the author).  
However, this study has also several limitations. The results from this study are entirely 
observational and no assessments of causality can be made (only hypothesised). Relatively 
few patients were recruited to this study and the follow-up only lasted 24 hours 
postoperative. Some of the data concerning postoperative pain, PONV and satisfaction were 
missing, especially from the assessment at evening operation day. In addition, some of the 
questions on the pain- and satisfactory form were suboptimal, and adjustments had to be 






patient satisfaction no other outcomes or complications were assessed Clear cut-offs to 
assess adherence/no-adherence to the new protocol were also not established.  
4.4 Implications of this study 
The results from this study have been presented to the physicians and nurses at the 
Anaesthesia Department, PACU, Orthopaedic ward and Orthopaedic Department at UNN 
Tromsø. Hopefully this will increase the adherence to the new protocol and improve the 
documentation of patient medication. Increased adherence to the new protocol may 
improve postoperative pain and PONV following fast-track primary TKA at UNN Tromsø. 
Failure to improve the documentation of patient medication may threaten the patient safety 
and potentially cause harm.  
A new study should be conducted to see if the adherence to the new protocol and the 
documentation of patient medication were improved following this study. Similar studies 
should also be conducted for other surgical procedures at UNN Tromsø to evaluate the 
quality of care and patient safety.  
In addition to the implications of this study at UNN Tromsø, the results were also presented 








5 Conclusion  
Adherence to the new protocol for fast-track primary TKA at UNN Tromsø was low. Despite 
low adherence to the new protocol patient satisfaction following fast-track primary TKA at 
UNN Tromsø was high. Postoperative pain scores and PONV following fast-track primary TKA 
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Table 1 Demographics 
Gender (male/female) 14/14 
Age (years) 65 (13) 
BMI (kg/m2) 30,3 (5,1) 
ASA-classification (I/II/III) 1/20/7 
Knee (left/right)  13/15 
Opioid naive  26 
Demographics of the 28 patients included in the study. Mean (SD) or number (n). Continuous 
variables are presented as mean (standard deviation); categorical variables are presented as 
counts. BMI, body mass index; ASA, American Society of Anesthesiologists; Opioid naive, 
patient not using any opioids upon hospitalization.  
 
Table 2 Adherence to preoperative measures 
Premedication according to protocol?  
(yes/no) 
3/25 
Preoperative paracetamol according to protocol?  
(yes/too low dose/no) 
6/20/2 
Preoperative naproksen 500 mg/ esomeprazol 20 mg according to protocol? 
(yes/no) 
15/13* 
Preoperative tapentadol 50 mg or oksykodonhydroklorid 10 mg (>70 years) 
according to protocol? 
(yes/no) 
22/6 
No preoperative benzodiazepines according to protocol? 
(yes/no) 
25/3† 
Preoperative bladder emptying controlled and correctly documented according 







(yes/not correctly documented/no) 
Adherence to the preoperative measures stated by the new protocol. *One patient did not 
receive naproksen/ esomeprazole due to allergy. †One patient received benzodiazepine as 
part of regular medication.  
 
Table 3 Adherence to intraoperative measures 
Spinal anaesthesia according to protocol? 
(yes/general anaesthesia) 
26/2 
LIA according to protocol?  
(yes/wrong dose/unknown dose) 
4/22/2 
Dexametasone according to protocol? 
(yes/wrong dose/no) 
10/4/14 
First dose of tranexamic acid according to protocol? 
(yes/no) 
28/0 
Second dose of tranexamic acid according to protocol? 
(yes/wrong timing)  
26/2 
Adherence to the intraoperative measures stated by the new protocol. LIA, local infiltration 
analgesia.  
 
Table 4 Adherence to antibiotic prophylaxis 
PA first dose 
(yes/wrong timing) 
20/8 
PA second dose  
(yes/wrong timing) 
23/5 
PA third dose 







PA fourth dose 
(yes/wrong timing/wrong dose/no) 
5/20/1/2 
Adherence to prophylactic antibiotics stated by the new protocol and national guidelines. 
PA, prophylactic antibiotics.  
 
Table 5 Adherence to postoperative measures 
Postoperative medication according to protocol? 
(yes/no) 
9/19 
Postoperative paracetamol according to protocol? 
(yes/wrong dose/wrong timing) 
26/1/1 
Naproksen 500 mg, esomeprazol 20 mg according to protocol? 
(yes/no) 
15/13* 
Tapentadol 50 mg according to protocol?  
(yes/no) 
18/10 
Adherence to postoperative measures stated by the new protocol. *One patient did not 
receive naproksen 500 mg/ esomeprazole 20 mg due to allergy.  
 
Table 6 Postoperative nausea and vomiting (yes/no/missing) 
Arrival PACU                                              0/28/0 
1-hour postoperative                             3/25/0 
2-hours postoperative                            1/26/0 
Discharge PACU                                        2/22/0 
Arrival Orthopaedic Ward                      2/23/3 
Evening operation day                            6/14/8 






Postoperative nausea and vomiting reported by the patients in the study. Yes, 
nausea/vomiting now or since last assessment; no, no nausea/vomiting now or since last 
assessment. Missing, patient data not registered.  
 
Table 7 Patient satisfaction (satisfied/unsatisfied/missing) 
Arrival PACU                                              24/2/2 
1-hour postoperative                             26/0/2 
2-hours postoperative                            25/0/3 
Discharge PACU                                        23/0/5 
Arrival Orthopaedic Ward                      25/0/3 
Evening operation day                            14/1/13 
Postoperative day 1                                 27/1/0 
 Satisfaction level reported by the patients in the study. Missing, patient data not registered.  
 
Table 8 Locations of the worst pain focus 
(anteromedial/posterior/other/none/missing) 
Arrival PACU                                              4/0/1/23/0 
1-hour postoperative                             4/0/2/21/1 
2-hours postoperative                            5/0/3/15/5 
Discharge PACU                                        13/0/3/6/6 
Arrival Orthopaedic Ward                      13/1/5/6/3 
Evening operation day                            8/1/4/1/14 
Postoperative day 1                                 18/4/6/0/0 
Locations of the worst pain focus reported by the patients in the study. Missing, patient data 








Figure 1 Postoperative resting pain 
 
Postoperative resting pain at seven points during the first 24 hours postoperative. Data is 
shown as a box-plot with ranges (whiskers), interquartile ranges (boxes), medians (solid 
lines) and outliers (circles or stars). Outliers represented as circles are cases with values 
between 1.5 and 3 box lengths from the upper or lower edge of the box. Outliers 
represented as stars are cases with values above 3 box lengths from the upper or lower edge 






9 Appendices  
➢ Appendix A: The new anaesthesia protocol containing LIA for fast-track primary TKA 
at UNN Tromsø implemented in January 2017.  
➢ Appendix B: The pain- and satisfaction form used to collect patient data in the study.  
➢ Appendix C: Study approval from Data protection officer at UNN Tromsø  
➢ Appendix D: GRADE 1 
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Retningslinjen skal sikre at pasienter som får anestesi ved Fasttrack kneproteser 
får sikker behandling og et godt postoperativt resultat.  
Denne prosedyren gjelder ikke bytte av proteser der det er forventet 




Ved Fasttrack protese kirurgi er hovedmål en pasient som kan mobiliseres tidlig. 
Pasienter skal ut av sengen og stå på operert ben operasjonsdagen. 
 
LCS- kneprotese: 
Til alle som trenger kneprotese pga: 
Primær artrose  
Sekundær artrose etter ulike skader 
Reumatoid artrittpasienter  












Inkluderte: Alle. Pasienten tilses på Kneskole i henhold til avdelingens rutiner. 
ASA III må vurderes individuelt iht grunnsykdom (3,4,6) 
 
Eksklusjon: Ingen. Komplekse kroniske smertepasienter som LAR pasient 
skal vurderes individuelt. 
 
Tromboseprofylakse forordnes av ortoped etter gjeldende retningslinjer 
PR13776 Tromboseprofylakse (Fragmin)- Ortopedi- og plastikkirurgisk avdeling (ORPL) UNN. 
 








Dette er kun en papirkopi. Gyldig versjon av dokumentet finnes i det elektroniske kvalitetssystemet.  Side 1 av3 
Skrevet ut: 11.12.2017 13:06:51 Gyldig fra: 31.01.2017 
 
Anestesi ved Fasttrack kneprotese 
 






Premedikasjon: Gis på sengepost etter gjeldende prosedyre. Forordnes av ortoped 
(1, 4).  
Paracetamol tbl 1g til pasient <70kg og 2g til pasient >70kg 
Vimovo 1tbl, 500 mg/20mg (Naproxen/ Esompreazol)  
Palexia depot tbl 50 mg (µ-opioid) per os gis rutinemessig etter 
gjeldende retningslinjer såfremt det ikke foreligger sterke 
kontraindikasjoner. Alternativ til eldre>70 år: OxyContin tbl 10mg  
Benzodiazepiner gis ikke. . 
 
Blæretømming pre.opr: Ansvarlig sykepleier ved sengepost tilser at pasienten tømmer 
urinblæren like før overflytting til operasjonsenhet og dokumenterer tidspunkt på 






Forberedelse av pasienten og bedøvelse foregår vanligvis på innledningsrom 
og fullføres på operasjonsstuen. 
 
Utstyr/ monitorering: Venekanyle, O2 på nesekateter, EKG-monitorering, 
pulsoxymetri, 
non-invasiv (evt invasiv BT-måling),Tempmåling(øre), varmluftslaken 
 
Anestesimetode: Som hovedregel velges regionalanestesi. Spinal er førstevalget. 
Marcain (bupivacaine) 0.5% plain, helst i nivå L2-3.  
Viktig! Pasienten skal være totalt avslappet i beinet, for at operatøren skal 






Antibiotica: (5): Cefalotin 2g x 4 iv 
1.dose:30-60min før kirurgi. 
2.dose: (ca.90min etter 1.dose) avtal 2.dose med kirurg pga blodtomhet 
 
Fibrinolysehemmer: Traneksamsyre 10mg/kg 
1.dose gis 15min før blodtomhet slippes opp. Ortoped gir beskjed! 
2.dose gis 3timer etter 1.dose.  
Traneksamsyre gis såfremt det ikke foreligger kontraindikasjoner. Ordineres av 
ortoped. 
Prosedyre PR30319 Cyklokapron ved protesekirurgi 
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Tibiadel med sement og Femurdel uten eller med sement.  
Roterende plattform av plast mellom femur og tibia muliggjør anatomisk bevegelse 
i kneledd.  
Når sementering begynner starter vi klokka. Første 3 minutt beskjed hvert 30. 
sekund.  
Så hvert minutt til 10 min. 
 
Lokalanestesi: Ropivakain 2 mg/ml 120-150 ml tilsatt Adrenalin settes av ortoped 
under lukning av sår. 
 
Blærescanning og evt.engangskateterisering:  





Væske: Rest Ringer Acetat 
 
Smertelindring: (forordnes av lege):  
Paracetamol tbl. 1 eller 1,5g x 4 
Vimovo tbl. 500mg/20mg x 2  
Palexia depot tbl. 50mg x 2 
Morfin iv v/behov  
OxyNorm 5 mg v/behov på sengepost. 
 
Studier viser at denne smertelindring fungerer for over 90% av pasienter. For 
pasienter som ikke kan få NSAIDS eller som har stor, uforventet smerte vil andre 
løsninger være indisert, f.eks. nerveblokade, epidural, PCA eller andre opioider. 
 






1. Anestesiologisk metode Fast-track hofte- og kneprotese Ortopedisk avdeling, St.Olavs 
Hospital, Trondheim.  
2. Miller (kap 61; Anesthesia for Orthopedic Surgery).  
3. Avdelingens praksis 
4. Ortopedisk avdelings praksis. 
5. Antibiotika i sykehus. Nasjonal faglig retningslinje for bruk av antibiotika i sykehus(Helsedirektoratat) 
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Postoperativ smerte hos pasienter som har fått innsatt total kneprotese 
 
Skjemaet følger pasientkurven.                                                                  Pasient id(navnelapp): 
Ved spørsmål, vennligst kontakt stud.med. Arnstein Berg tlf. 93442740 eller professor Lars Marius Ytrebø tlf. 90788058 
 Ankomst på 
oppvåkningen 




Kveld opr dagen 
(ca 8 t postopr) 
Postopr dag 1 
(ca 24 t postopr) 
Klokkeslett         
Smertegrad nå (NRS 0-10)        
Maks grad av smerte i ro 
siden sist måling (NRS 0-10) 
       
Minste grad av smerte i ro 
siden sist måling (NRS 0-10)  
       
Gjennomsnittlig smerte i ro 
siden sist måling (NRS 0-10) 
       
Det sterkeste  
smertefokuset i kneet nå 
(ant/med/lat/post/globalt) 
       
Kvalme nå/siden sist (ja/nei)        
Oppkast nå/siden sist (ja/nei)        
Pasienttilfredshet nå (en av 
de fem kategoriene under): 
-Svært fornøyd (1) 
-Meget fornøyd (2) 
-Fornøyd (3) 
-Misfornøyd (4) 
-Svært misfornøyd (5)  
       
APPENDIX B: 
Ved spørsmål, vennligst kontakt stud.med. Arnstein Berg tlf. 93442740 eller professor Lars Marius Ytrebø tlf. 90788058 
Eventuelle 
kommentarer/begrunnelser 




fra pasient  
 
     
Postadresse: Avdeling: Kvalitets- og utviklingssenteret Telefon: 07766 
UNN HF Besøksadr.:  Internett: www.unn.no 
9038 TROMSØ Fakturaadr: UNN HF, c/o Fakturamottak, Postboks 3232, 7439 Trondheim E-post: personvernombudet@unn.no 
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Reference: Andersen LO, Husted H, Otte KS, et al. High-volume infiltration analgesia in total knee arthroplasty: a randomized, double-





GRADE:   ⊕⊕⊕⊕ 










Twelve consecutive patients scheduled for total bilateral knee arthroplasty were 
included from October 2006 to April 2007. Inclusion criteria: consecutive 
patients scheduled for total bilateral knee arthroplasty, able to understand and 
speak Danish and able to give informed oral and written consent to participate. 
Exclusion criteria: treatment with opioids or steroids, rheumatoid arthritis or 
other immunological diseases, a history of stroke or any neurological or 
psychiatric disease potentially influencing pain perception, allergies to any of 
the drugs administered and a body mass index >40. Intervention: infiltration 
with 170 ml ropivacaine (0.2%) and epinephrine (10 μg/ml) in one knee, and 
similar infiltration with 170 ml of 0.9% saline in the opposite knee. Postoperative 
injection of the drug mixture [40 mg ropivacaine and epinephrine (10 μg/ml)] or 
0.9% saline was administered intra-articulary through the catheters placed 
during surgery in accordance with the randomization. All patients received PCA 
and the same multimodal pain management regime postoperatively. All 
inclusion and data registration were performed by one investigator. All 
anaesthetic procedures were performed by one of two anaesthesiologists and 
all patients were operated by one of two surgeons. Allocation of which knee 
was to receive active treatment was determined by randomization, using a 
computer‐generated random sequence and opaque sealed envelopes. To 
ensure complete blinding of the patients, the surgeon and the investigator 
recording post‐operative pain data, the randomization was not revealed until 
completion of the entire study. The medicine used for each individual patient 
was prepared by one investigator not otherwise involved in patient data 
collection. The primary end‐point was to compare post‐operative pain in each 
leg, which was assessed using a Numeric Rank Scale (NRS) from 0 to 10, at 
rest, upon 45° flexion of the knee and with the leg straight and 45° elevated. 
Pain was recorded at 4, 8, 9, 24, 24.5, 25, 26, 32 and 48 h post‐operatively. 
Throughout the 48‐h study period, the amount of morphine delivered via the 
PCA pump as well as the length of hospital stay were registered. All patients 
were discharged directly to their homes and discharge criteria were functional: 
ability to get in and out of bed, get dressed, get into and up from a chair, ability 
to walk independently for 50 m with appropriate walking aids and acceptance of 
discharge. The number of participants was arbitrarily set to 12, because no 
meaningful power calculation could be performed from previously published 
data in unilateral knee replacement. Tests for significant differences between 
treatment groups were performed using the Wilcoxon signed ranks test. P 
values <0.05 were considered statistically significant. All data analysis was 
performed using SPSS for windows, ver. 12.0 (SPSS Inc., Chicago, IL). 
Twelve consecutive patients were 
included because no patients refused 
to participate. Patient characteristics 
were seven men/five women, mean 
age 69 years (range 57–87), mean 
weight 85 kg (range 67–101), mean 
body mass index 29 (range 25–36) and 
American Society of Anesthesiologists 
Physical Status I/II/III=3/8/1. NRS pain 
scores were significantly lower from the 
knee infiltrated with ropivacaine and 
epinephrine compared with the knee 
infiltrated with saline. This reduction in 
NRS pain scores was significant from 4 
to 25 h post‐operatively at rest, from 4 
to 32 h post‐operatively upon 45° 
flexion of the knee and from 4 to 26 h 
post‐operatively when the leg was 
straight and 45° elevated. In the PACU, 
[median (interquartile range)] iv 
administration of morphine was 20 mg 
(0–75 mg) and cumulated post‐
operative PCA morphine administration 
[median (interquartile range)] was 8 mg 
(4–14), 19 mg (9–32), 35 mg (22–56), 
48 mg (26–70) and 58 mg (33–86) at 4, 
8, 24, 32 and 48 h post‐operatively. 
The mean duration of surgery was 109 
min (range 64–150). Hospital stay 
(median) was 4 days (range 3–19). A 
detailed description of study side 
effects was not performed, but no 
major side effects, including cardiac 
and hemodynamic changes requiring 
treatment, were observed in the study 
period (intraoperatively and 0–48 h 
post‐operatively). 
Checklist: 
-Did the trial address a clear 
question? Yes 
-Was the assignment of patients to 
treatments randomised? Yes 
-Were all patients who entered the 
trial properly accounted for at its 
conclusion? Yes 
-Were patients, health workers and 
study personnel ‘blind’ to treatment? 
Yes 
-Were the groups similar at the start 
of the trial? Yes (patients served as 
their own controls)  
-Aside from the experimental 
intervention, were the groups 
treated equally? Yes 
-How large was the treatment 
effect? Significant differences in 
median NRS ranged between 1 and 
6 
-How precise are the estimates of 
the treatment effect? Significant 
differences were either P<0,05 or 
P<0,01 
-Can the results be applied to the 
local population? Yes 
-Were all clinically important 
outcomes considered? Yes 
-Are the benefits worth the harms 
and costs? Yes   
 
Strengths: 




Morphine requirements could not be 






















Year of data 
collection 
October 2006 
to April 2007 
APPENDIX E: 
 
Reference: Busch CA, Shore BJ, Bhandari R, et al. Efficacy of periarticular multimodal drug injection in total knee arthroplasty. A 





GRADE:   ⊕⊕◯◯ 
Objective Methods and materials Results Discussion/ comments 
Investigate the use 
of a periarticular 
injection of 
multimodal drugs, 











following total knee 
arthroplasty. 
64 patients undergoing unilateral TKA were randomized with the use of 
randomization tables. 32 patients received an intraoperative periarticular 
injection of analgesic drugs, and 32 patients did not. Inclusion criteria: 
age < 80 years, weight 50-120 kg, and an ability to provide informed 
consent for, and cooperate with, the study. Exclusion criteria: major 
psychological problems, previous drug dependency, allergies to any of 
the ingredients of the injection, renal insufficiency, abnormal liver 
enzymes, a history of stroke or a major neurological deficit, or 
uncontrolled angina and bifascicular blocks with prolonged QT intervals. 
The knee arthroplasty was performed through a standard medial 
parapatellar approach. The injection contained 400 mg of ropivacaine, 30 
mg of Toradol (ketorolac), 5 mg of epimorphine, and 0.6 mL of 
epinephrine (1:1000). These were mixed with sterile normal saline 
solution to make up a combined volume of 100 mL in the operating room. 
Operative anaesthesia was either general or regional. The anaesthetic 
regimen was standardized. Five patients had blood samples taken at 
thirty minutes, one hour, and four hours postoperatively to measure 
venous blood (proteinbound) ropivacaine levels. All patients received 
PCA for 24 hours after the surgery. The consumption of PCA was 
measured at different time-points during the 24 postoperative period and 
the patient’s overall analgesic consumption was measured and converted 
to morphine equivalents to allow for comparison of the two treatment 
groups. Patients used VAS to assess pain, both at rest and during 
activity, as well as their satisfaction in the preoperative assessment clinic 
(two to three weeks prior to the surgery), on the day of the surgery, in the 
PACU, during the inpatient stay, and finally at the six-week follow-up 
examination. The VAS for pain and satisfaction ranged from 0 mm 
(indicating no pain or completely dissatisfied) to 100 mm (indicating 
extreme pain or completely satisfied) in 10-mm increments. Specific note 
was made of any signs of cardiac or central nervous system toxicity or 
wound complications. Knee Society clinical rating scores13 and scores 
according to the Western Ontario and McMaster Universities 
Osteoarthritis Index (WOMAC)14 were collected prospectively for all 
patients. All patients had an ultrasound study of the lower limb to screen 
for deep vein thrombosis at five days after the surgery. Statistical analysis 
of the data set was performed with use of the Kolmogorov-Smirnov test (p 
< 0.05) for normality and subsequently a normal t test. The analyses were 
performed with SPSS software (version 11.5; SPSS, Chicago, Illinois). 
Patients who had received the 
multimodal drug infiltration used 
significantly less patient-controlled 
analgesia at six hours (p < 0.01) and at 
twelve hours (p = 0.016) and had a 
significantly lower overall requirement 
for patient-controlled analgesia over the 
first twenty-four hours after surgery (p 
<0.001) compared with the patients 
who had received no infiltration. There 
was no difference in the overall 
analgesic consumption in morphine 
equivalents between the two patient 
groups. The group that had had the 
infiltration had significantly greater 
mean VAS for patient satisfaction in the 
PACU (p = 0.016) and four hours 
postoperatively (p = 0.013) and 
significantly lower VAS for pain during 
activity in the PACU (p = 0.04) and at 
four hours after the surgery (p = 0.007). 
There was no difference between 
treatment groups regarding the 
numbers of patients receiving general 
or spinal anaesthesia (p = 0.446). At six 
weeks, no significant difference in the 
range of motion could be detected 
between the two groups. In addition, 
with the numbers available, there was 
no significant difference in the average 
hospital stay or the rate of wound 
complications between the two groups. 
One patient who had received the 
infiltration had a deep vein thrombosis 
postoperatively. The maximum level of 
unbound ropivacaine observed was 60 
ng/mL, which is 2.5 times below the 
toxic level (150 ng/mL).  
Checklist: 
-Did the trial address a clear 
question? yes 
-Was the assignment of patients to 
treatments randomised? yes 
-Were all patients who entered the 
trial properly accounted for at its 
conclusion? yes 
-Were patients, health workers and 
study personnel ‘blind’ to treatment? 
No, only patients were blinded  
-Were the groups similar at the start 
of the trial? yes 
-Aside from the experimental 
intervention, were the groups 
treated equally? yes 
-How large was the treatment 
effect? Ranging between 0-20 mm 
VAS.  
-How precise are the estimates of 
the treatment effect? See the results 
-Can the results be applied to the 
local population? yes 
-Were all clinically important 
outcomes considered? yes 
-Are the benefits worth the harms 
and costs? yes 
 
Limitations:  
Only patients were blinded. 
Anaesthesia technique was not 
standardized. No systemic 




















satisfaction, with no 
apparent risks, 









Reference: Fan L, Yu X, Zan P, et al. Comparison of Local Infiltration Analgesia With Femoral Nerve Block for Total Knee Arthroplasty: 





GRADE:  ⊕⊕⊕◯ 
Objective Methods and materials Results Discussion/ comments 
Evaluate the effect 




after TKA by 
comparing with 
single shot FNB. 
Prospective, patient- and assessor-blinded, single-center 
randomized controlled trial. Included: all patients scheduled to 
undergo primary TKA at Shanghai Tenth People's Hospital from 
May 2012 to September 2014. Excluded: patients with known 
allergies to any of the test drugs, those with major systemic 
illnesses, chronic users of opioids or NSAIDS, a history of deep 
vein thrombosis, and previous knee surgery. A total of 183 
patients were eligible for the study, and 23 patients were 
excluded based on the exclusion criteria. Then 160 eligible 
patients undergoing TKA were prospectively randomized to 1 of 
2 study arms using sealed, opaque envelopes that were 
opened before surgery.  
Interventions: FNB was performed preoperatively: 20mL of 
ropivacaine 0.5% in group A (FNB) and normal saline in group 
B (LIA). Two experienced anaesthesiologists performed the 
nerve block and were not blinded to the treatment allocation. 
After cementing the prostheses, 50 mL of cocktail mixture 
containing morphine (1 mL: 10 mg), ropivacaine (10 mL: 100 
mg), and diprospan (1 mL: 5 mg betamethasone dipropionate 
and 2 mg betamethasone sodium phosphate) was injected into 
the periarticular soft tissue in group B. In group A, cocktail was 
replaced by normal saline. The LIA procedure was conducted 
by 2 chief surgeons who were not blinded. After surgery, all 
patients received PCA and equal fluid- and pain management.  
Outcomes measurement: morphine consumption of the PCA, 
VAS at rest and with movement, Knee Society Score (KSS) and 
ROM before and after surgery, inpatient days, complications 
(including nausea and vomiting, urinary retention, infection, 
deep venous thrombosis, hematoma, and nerve injury) were 
collected and analysed. 
Data Analysis: Statistical analysis was performed with SPSS 
statistical software 20.0. The results were presented as the 
mean ± standard deviation. Student's t test was used for 
normally distributed parameters, and the chi-square test was 
used for proportional data. A P value <0.05 was regarded as 
statistically significance. 
A total of 160 patients were successfully 
recruited and 3 patients were withdrawn after 
protocol violation. There was one patient in 
each group who received spinal rather than 
general anaesthesia, and one patient who was 
randomized to the group A failed to complete 
the follow-up. Finally, there were 78 patients in 
group A and 79 patients in group B. Patient 
demographics and surgery details showed no 
statistical difference between 2 groups. There 
was no significant difference between 2 groups 
with respect to the daily and the cumulative 
morphine consumption of PCA. As to the pain 
scores, the local infiltration group (group B) had 
less pain as measured with the VAS during the 
first 24 hours only (7.1 of 0.6 vs 6.9 of 0.5, P = 
.01), compared with group B. Thereafter, no 
significant difference was observed between 
the 2 groups. The ROM, KSS, and length of 
stay showed no significant differences. 
Eighteen patients in group A and 21 patients in 
group B experienced mild-to-medium nausea or 
vomiting, and 10 patients in group A and 15 
patients in group B were given metoclopramide 
5-10 mg during the study. No urinary retention 
case was seen during inpatient days. One 
patient in group B had dizziness, and no special 
treatment was given. One patient in group A got 
femoral nerve injury and her quadriceps power 
dropped to level 2, which was recovered to 
level 5 after 45 days rehabilitation training. 
Each group had one case of deep venous 
thrombosis, and patients were given 
thrombolytic anticoagulant therapies. In both 
groups, there was neither prolonged wound 
discharge nor deep surgical site infection.  
 Checklist: 
-Did the trial address a clear question? 
Yes 
-Was the assignment of patients to 
treatments randomised? Yes 
-Were all patients who entered the trial 
properly accounted for at its 
conclusion? Yes 
-Were patients, health workers and 
study personnel ‘blind’ to treatment? 
No, but patients and assessors were 
blinded.  
-Were the groups similar at the start of 
the trial? Yes 
-Aside from the experimental 
intervention, were the groups treated 
equally? Yes 
-How large was the treatment effect? 
The local infiltration group had less 
pain measured with the VAS during the 
first 24 hours (7.1 of 0.6 vs 6.9 of 0.5, P 
= .01),   
-How precise are the estimates of the 
treatment effect? See the previous 
question 
-Can the results be applied to the local 
population? Yes 
-Were all clinically important outcomes 
considered? Yes 
-Are the benefits worth the harms and 
costs? Yes  
 
Limitations  
The morphine use after surgery does 
not represent the tendency of analgesia 
used today, which is to avoid morphine 










the 2 treatment 
groups. LIA could 
provide a similar 
analgesic effect to 





Year of data 
collection 




Reference: Roberts GW, Bekker TB, Carlsen HH, et al. Postoperative nausea and vomiting are strongly influenced by postoperative 
opioid use in a dose-related manner. Anesthesia and analgesia 2005; 101: 1343-8. 




GRADE:  ⊕⊕⊕◯ 
Objective Methods and materials Results Discussion/ comments 
Examine the effect 
of known risk factors 
for POV, with a 
focus on the 
relationship 
between vomiting 
and opioid use in 
the 48 h 
postoperatively. 
All patients receiving surgical procedures requiring 
anaesthesia (excluding local anaesthesia) with an 
expected length of stay of ≥2 days who did not receive 
perioperative antiemetic prophylaxis were eligible. The 
approach to analgesia for any given patient was at the 
discretion of the anaesthesiologist. Those patients not 
using epidural analgesia or PCA were given pain relief 
with a combination of IV and oral medication, on an “as 
required” basis. Patients already receiving drugs with 
antiemetic properties, including corticosteroids, were 
excluded. An episode of POV was defined as vomiting 
or retching over any 2-min period. The severity or 
duration of nausea was not recorded, only if it was 
present or not, as determined by the patient. Patients 
who vomited were automatically included as having 
experienced nausea at that point. Patients routinely 
received postoperative rescue antiemetics if they 
vomited, or experienced ≥10 min of debilitating nausea. 
In the first instance, they received 10 mg of IV 
metoclopramide, followed 10 min later by 4 mg of IV 
ondansetron if the nausea and vomiting were still not 
controlled. Nausea and vomiting episodes were 
recorded 0.5, 1, 2, 4, 8, 12, 24, and 48 h 
postoperatively. Opioid doses, both intra- and 
postoperative, were recorded for the 0- to 24-h and 24- 
to 48-h periods postoperatively. All opioid doses, 
regardless of route of administration or type of opioid, 
were converted to the equianalgesic dose of IV 
morphine for comparative purposes. These values were 
predetermined on current available literature and the 
clinical expertise of the participating anaesthesiologists. 
Fentanyl was used for all epidurals and was considered 
equipotent via epidural or IV route. One milligram of IV 
morphine was considered to be equianalgesic with 10 g 
of spinal morphine. Parametric data were compared 
using a Student’s t-test. Kaplan-Meier plots were used 
to examine the incidence of POV over time. Cox 
regression analysis was used to examine variables 
influencing POV. The significance level was set at 5%. 
Data were collected on 193 patients. In the first 24 h 
postoperatively, 23.8% of patients experienced POV and 
a further 27.5% experienced PON with no associated 
vomiting. In the 24- to 48-h postoperative period, 6.5% of 
patients vomited and a further 23.2% experienced 
nausea only. Cox regression analysis included gender, 
history of POV or motion sickness, smoking, duration of 
anaesthesia, age, and opioid dose, and revealed only 
opioid use (P = 0.025) and female gender (P = 0.038) as 
factors influencing POV. Use of PCA or epidural 
analgesia were markers for large-dose opioid use in the 
first 24 h (91.5 and 83.2 mg of morphine or equivalent for 
PCA and epidural analgesia, respectively, versus 17.5 
mg for non-users, P 0.001). This was associated with 
more frequent POV and PON. Patients not using PCA or 
epidural analgesia experienced less POV and PON (P 
0.001 for both). Those patients who experienced POV 
and PON in the 24- to 48-h period postoperatively had 
significantly larger opioid use during this period than 
those who did not (P 0.01 for both). Patients were 
divided into quartiles according to opioid dose to further 
examine the relationship between opioid dose and POV 
in the first 24 h postoperatively. There was a strong 
logarithmic dose-response relationship with POV (r2 = 
0.98, P < 0.01), as well as PON (r2 = 0.98, P = 0.01). 
When patients receiving opioids via the spinal or epidural 
route were removed from analysis, this relationship 
remained largely intact, although the dose-response 
relationship with POV in this subgroup was better suited 
to a linear relationship (r2 = 0.99, P 0.01 for linear, r2 = 
0.82, P = 0.09 for logarithmic, n = 145). PON remained 
best correlated to a logarithmic relationship (r2 = 0.99, P 




-Did the study address a clearly 
focused issue? Yes 
-Was the cohort recruited in an 
acceptable way? Unclear 
-Was the exposure accurately 
measured to minimise bias? Yes 
-Was the outcome accurately 
measured to minimise bias? Yes 
- Have the authors identified 
all important confounding factors? 
Unclear  
-Have the authors taken account of 
the potential confounding factors in 
the design and/or in their analysis? 
Yes  
-Was the follow up of subjects 
complete enough? Yes 
-Was the follow up of subjects long 
enough? Yes 
-How large was the treatment effect? 
Large, dose-response relationship 
-How precise was the estimate of the 
treatment effect? Precise, see the 
results 
-Do you believe the results? Yes 
-Can the results be applied to the 
local population? Yes 
-Do the results of this study fit with 
other available evidence? Yes 
-What are the implications of this 
study for practice? Reduce the use of 
opioids for postoperative pain 
management to avoid PONV (or use 
adequate prophylaxis in risk patients). 
  
Limitations  





There is a strong 
relationship 
between the amount 
of postoperative 
opioid used and 
POV. The accuracy 
of various risk 
scoring approaches 
may have been 
undermined by not 
allowing for this 
relationship. 




be priority targets 












Reference: Essving P, Axelsson K, Kjellberg J, et al. Reduced morphine consumption and pain intensity with local infiltration analgesia (LIA) 





GRADE:   ⊕⊕⊕⊕ 
Objective Methods and materials Results Discussion/ comments 
Evaluate if LIA 
reduces morphine 
consumption during 





intensity, time to 
home readiness, 
side effects, plasma 
concentrations of 
LA, knee function, 
and patient 
satisfaction. 
78 consecutive TKAs because of osteoarthritis were screened for eligibility. 
Inclusion criteria: age 20–85 years, ASA I–III, and normal preoperative mobility. 
Exclusion criteria: known allergy or intolerance to one of the study drugs, serious 
liver-, heart- or renal disease, inflammatory joint disease, chronic pain, or any 
bleeding disorder. 30 patients were excluded prior to randomization due to 
exclusion criteria. Patients were randomised into 2 groups with 24 patients in each, 
using computer-generated randomized numbers. The patients, the 2 study 
investigators, the study physiotherapist, and all the staff concerned with the 
postoperative care of the patients were blinded to the group randomization. All 
patients received general anaesthesia. In group A, 400 mg ropivacaine, 30 mg 
ketorolac, and 0.5 mg epinephrine (total volume 166 mL) were infiltrated by the 
surgeon into the soft tissues periarticularly during the operation. Group B received 
no intraoperative injection. After 21 h, 200 mg ropivacaine, 30 mg ketorolac, and 
0.1 mg epinephrine in total volume of 22 mL were injected intraarticularly in group 
A and a similar volume of saline was injected in group P. All patients received the 
same postoperative pain medication. CA-morphine consumption was recorded 
during 0–24, 24–48, and 0–48 h postoperatively. Oral analgesic consumption was 
recorded during 0–24, 24–48, and 0–48 h. Total analgesic consumption 0–48 h 
postoperatively was calculated using equivalent dose of intravenous morphine. 
Pain assessment (VAS) was made preoperatively and at 3, 6, 12, 21, 22 (i.e. 1 h 
after test drug injection), 27, and 48 h, and also on days 3 and 14, and at 3 months 
postoperatively. Pain was assessed both at rest and on flexion of the knee by 60 
degrees. The time to fulfillment of discharge criteria (home readiness) was 
recorded by a physician and the study physiotherapist. All complications and 
adverse events were registered intraoperatively and postoperatively, and also after 
discharge. Any hospital re-admissions during the 3-month follow-up period 
postoperatively were also recorded. An evaluation of patient satisfaction was done 
using a 4-grade verbal rating scale (excellent = 4, good = 3, inadequate = 2, poor = 
1) during the first 24 postoperative hours and after 7 days. A power analysis was 
done before the start of the study using morphine consumption over 48 hours 
postoperatively as the primary endpoint. The Mann-Whitney U test was used for 
the analysis of the primary endpoint (morphine consumption) since we found that 
the data were not normally distributed. Mann-Whitney U test was used to assess 
pain scores and the Bonferroni-Holm method was used to correct for multiple 
measures. Hospital stay, and patient satisfaction scores were also analyzed using 
the Mann-Whitney U test. Dichotomous data were analyzed using the chi-squared 
test or Fisher's exact test, as appropriate. Values of p < 0.05 were considered to be 
statistically significant. 
Median morphine consumption 
during the first 48 h 
postoperatively was lower in 
group A than in group P: 18 (1–
74) mg vs. 87 (36–160) mg (p < 
0.001), i.e. there was a median 
difference of 69 (95% CI: 47–86) 
mg. The proportion of patients 
who requested ≥ 5 mg morphine 
during the first 24 h was 
significantly less in group A than 
in group P (0/23 vs. 10/24) (p < 
0.01). Median total analgesic 
consumption (tramadol + 
morphine) during the first 48 
postoperative hours was 54 (4–
114) mg and 109 (37–221) mg, 
respectively (p < 0.001). Median 
VAS pain score was statistically 
significantly lower in group A than 
in group P at 3, 6, 12, 21, 22, and 
27 h. On movement, median VAS 
pain score was statistically 
significantly lower in group A than 
in group P at 3, 6, 12, 22, 27, and 
48 h. Median time to home 
readiness was shorter in group A 
than in group P, 3 (1–7) vs. 5 (2–
8) days (p = 0.03). The median 
length of hospital stay (LOS) was 
shorter in group A than in group 
P, 4 (2–8) days vs. 6 (3–10) days, 
but this was not statistically 
significant (p = 0.06). Patient 
satisfaction scores differed 
between the groups on day 1 (p < 
0.001) and on day 7 (p = 0.02). 
No major adverse effects were 
reported.  
 Checklist: 
-Did the trial address a clear 
question? Yes 
-Was the assignment of patients 
to treatments randomised? Yes 
-Were all patients who entered 
the trial properly accounted for 
at its conclusion? Yes 
-Were patients, health workers 
and study personnel ‘blind’ to 
treatment? Yes 
-Were the groups similar at the 
start of the trial? Yes 
-Aside from the experimental 
intervention, were the groups 
treated equally? Yes 
-How large was the treatment 
effect? Large, see results.  
-How precise are the estimates 
of the treatment effect? Precise, 
see results.  
-Can the results be applied to 
the local population? Yes 
-Were all clinically important 
outcomes considered? Yes 
-Are the benefits worth the 
harms and costs? Yes 
 
Limitations 
No intraoperative placebo.  
Surgeons and surgeon nurses 
were not blinded but did not take 







excellent pain relief 
and lower morphine 
consumption 
following TKA, 
resulting in shorter 













From April 2007 
through September 
2008.  
 
